Invited Review: Lung edema clearance: role of Na⁺-K⁺-ATPase

J Appl Physiol 93: 1860–1866, 2002. First published ; 10.1152/japplphysiol.00022.2002. highlighted topics Lung Edema Clearance: 20 Years of Progress Invited Review: Lung edema clearance: role of Na⫹-K⫹-ATPase J. I. SZNAJDER,1 P. FACTOR,1,2 AND D. H. INGBAR3 Pulmonary and Critical Care Medicine, Northwestern University, Chicago 60611; 2Evanston Northwestern Healthcare, Evanston, Illinois 60201; and 3Pulmonary, Allergy and Critical Care, Departments of Medicine and Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455 1 Sznajder, J. I., P. Factor, and D. H. Ingbar. Invited Review: Lung edema clearance: role of Na⫹-K⫹-ATPase. J Appl Physiol 93: 1860–1866, 2002. 10.1152/japplphysiol.00022.2002.—Acute hypoxemic respiratory failure is a consequence of edema accumulation due to elevation of pulmonary capillary pressures and/or increases in permeability of the alveolocapillary barrier. It has been recognized that lung edema clearance is distinct from edema accumulation and is largely effected by active Na⫹ transport out of the alveoli rather than reversal of the Starling forces, which control liquid flux from the pulmonary circulation into the alveolus. The alveolar epithelial Na⫹-K⫹-ATPase has an important role in regulating cell integrity and homeostasis. In the last 15 yr, Na⫹-K⫹-ATPase has been localized to the alveolar epithelium and its contribution to lung edema clearance has been appreciated. The importance of the alveolar epithelial Na⫹-K⫹-ATPase function is reflected in the changes in the lung’s ability to clear edema when the Na⫹-K⫹ATPase is inhibited or increased. An important focus of the ongoing research is the study of the mechanisms of Na⫹-K⫹-ATPase regulation in the alveolar epithelium during lung injury and how to accelerate lung edema clearance by modulating Na⫹-K⫹-ATPase activity. acute respiratory distress syndrome; alveolar epithelium; ion transport occurs as the result of active Na transport across the alveolar epithelium via apical amiloride-sensitive Na⫹ channels and basolateral Na⫹-K⫹-ATPases (19, 41, 57). This active vectorial Na⫹ flux produces a transepithelial osmotic gradient that causes water to passively move from the air spaces to the alveolar interstitium. In some models of acute lung injury and in patients with acute respiratory distress syndrome (ARDS), the lung’s ability to clear edema is impaired (3, 14, 16, 27, 49, 65, 72, 83, 89). Parallel studies in alveolar epithelial cells suggest that this impairment may be due to decreased function of epithelial Na⫹-K⫹-ATPase (13, 40, 49, 65). For example, severe lung injury in rats exposed to acute hyperRESOLUTION OF PULMONARY EDEMA ⫹ Address for reprint requests and other correspondence: J. I. Sznajder, Pulmonary and Critical Care Medicine, Northwestern Univ., 300 E. Superior, Tarry 14-707, Chicago, IL 60611. 1860 oxia (100% O2 for 64 h) reduces active Na⫹ transport in lungs and alveolar epithelial cells. However, moderate hyperoxic injury may lead to increased Na⫹-K⫹ATPase mRNA levels, with variable functional effects (16, 35, 62). Similarly, subacute hyperoxia (85% O2 for 7 days) is associated with proliferation of alveolar epithelial cells, upregulation of Na⫹-K⫹-ATPase in the alveolar epithelium, and increased lung edema clearance (63). Hypoxia also can inhibit the function of both alveolar epithelial Na⫹-K⫹-ATPase and the Na⫹ channel (17, 54, 55, 90). These observations suggest a paradigm in which during the acute phases of lung injury active Na⫹ transport may be impaired while edema accumulates due to changes in permeability of the alveolocapillary barrier. This acute phase is followed by a proliferative response associated with increased edema clearance (6, 63). Support for this model has been demonstrated in studies of patients with lung 8750-7587/02 $5.00 Copyright © 2002 the American Physiological Society Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022. http://www.jap.org 1861 INVITED REVIEW injury and ARDS in whom impairment of the lung’s ability to clear edema correlated with worse outcomes (14, 38). There is also ample experimental evidence from healthy animal models and during lung injury that upregulating the Na⫹-K⫹-ATPases increases active Na⫹ transport across the alveolar epithelium and thus edema clearance (4, 8, 24, 27, 71, 75, 76). Naⴙ-Kⴙ-ATPase STRUCTURE AND BIOCHEMISTRY The Na⫹ pump consists of two major subunits, ␣ and ␤, which typically form a heterodimer in the plasma membrane enzyme (79). In some tissues, there is a third ␥-subunit that modifies the functional activity of the enzyme, but its significance in lung is undefined. The essential role of Na⫹-K⫹-ATPase in cellular function has been recognized for more than 30 yr; more recently, its importance in the lung has been reported (6, 12, 27, 44, 62, 63). The ␣- and ␤-subunits have multiple isoforms; to date, four ␣- and five ␤-isoforms have been described (10, 61). These isoforms are expressed in a tissue-specific and developmentally regulated manner. The ␣- and ␤-subunits have ⬎70% homology between isoforms within each subunit; there also is significant homology of the Na⫹-K⫹-ATPase coding and promoter DNA sequences across species (50–52). The Na⫹-K⫹-ATPase ␣-subunit. The catalytic ␣-subunit exchanges intracellular Na⫹ for extracellular K⫹ in a 3:2 ratio and contains ouabain binding and phosphorylation sites. It has many transmembrane domains and forms the cationic pore. Transcriptional regulation studies of the rat Na⫹-K⫹-ATPase ␣1-subunit have identified a major transcription initiation site 262 bp upstream from the translation initiation site that is preceded by a TATA box at position ⫺32. Included in this 5⬘-flanking region are two highly conserved SP1 transcription factor-binding sites, two glucocorticoid response element half-consensus sequences (96), a consensus cAMP response element, and a positive regulatory region located at ⫺155/⫺49 bp from the transcription initiation site. An “Atp1a1” regulatory element (or ARE) at ⫺94/⫺69 bp binds both common and at least seven cell type-specific transcription factors, which could account for differential, cell-specific expression of this subunit (81). The human ␣1-gene promoter has a TATA box, five SP1-like elements (77), and three potential thyroid hormone response elements (29). In the lungs, the ␣2-subunit is expressed in alveolar epithelial cells and appears to have a role in alveolar fluid clearance (5). Polymorphisms of the human ␣2subunit have been linked to increased susceptibility to seizures (15), but lung abnormalities have not been associated with polymorphisms of any of the subunits or isoforms. Polymorphisms at one ␣2-locus decreases cardiorespiratory endurance (maximal oxygen consumption) with training by as much as 40% (68). The Na⫹-K⫹-ATPase ␤-subunit. The smaller ␤-subunit has a single transmembrane-spanning domain J Appl Physiol • VOL and, unlike the ␣-subunit, is glycosylated (59). The precise function of the ␤-subunit is controversial, but it appears to have a role in the assembly and trafficking of the Na⫹ pump heterodimer to the correct domain of the cell membrane, as well as membrane-associated half-life. In different cell types and tissues, the relative quantities of ␣ and ␤ mRNA and protein are variable. In rat alveolar type II cells and in the rat lung, the quantities of ␤-subunit seem to limit the functional activity of the Na⫹ pump enzyme (5, 27). Transcriptional regulation of the ␤1-subunit gene is less defined than for ␣1, but it is likely to be as or more important in the lung (37). Genomic clones of the rat ␤1-subunit promoter contain a potential TATA box at position ⫺31, four GC-rich boxes, and two sites with half consensus sequences for thyroid hormone response elements (53). Intron I of the rat ␤1-gene has a positive effect on basal transcription (C. H. Wendt and D. H. Ingbar, unpublished observations), but the specific regulatory elements involved are not defined. In the 5⬘upstream region, two major and three minor transcription initiation sites have been identified. There is also a positive regulatory region (⫺650 to ⫺630 bp) that is required for mineralocorticoid receptor or glucocorticoid receptor activation (21). The NH2-terminal region of the mineralocorticoid receptor inhibits GC stimulation of Na⫹-K⫹-ATPase ␤1-subunit transcription (46). Hyperoxia stimulates transcription of this subunit through an increase in the binding of SP1 transcription factor to the proximal promoter region (93). REGULATION OF ALVEOLAR EPITHELIAL Naⴙ-Kⴙ-ATPase Short-term regulatory mechanisms. Several reports have suggested that basal Na⫹-K⫹-ATPase activity in intact cells is one-third of its maximal capacity (78). Thus recruitment of this reserve capacity represents a mechanism by which cellular Na⫹-K⫹-ATPase activity can be rapidly upregulated. Short-term increases in Na⫹-K⫹-ATPase function can be regulated via three pathways: 1) changes in the number of molecules in the cell plasma membrane, 2) changes in the catalytic property of enzymes already present at the plasma membrane, and 3) changes in enzyme affinity for Na⫹. Recent data indicate that Na⫹-K⫹-ATPase activity can be rapidly increased via at least two mechanisms. First, both dopamine and ␤-adrenergic agonists increase lung edema clearance within 1 h (1, 4, 6, 27). The ␤-adrenergic agonists increase the pump’s affinity for Na⫹ and recruit Na⫹ pump subunit proteins to the basolateral plasma membrane from intracellular endosomal compartments (30) (see Fig. 1). In lung alveolar epithelial cells, activation of G protein-coupled receptors, via either dopaminergic or adrenergic stimuli, rapidly (30 s to 15 min) increases Na⫹-K⫹-ATPase activity by insertion of Na⫹ pump proteins from intracellular compartments into the plasma membrane (4, 48, 69) (see Fig. 2). These effects are dependent on a 93 • NOVEMBER 2002 • www.jap.org Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022. 1862 INVITED REVIEW Fig. 1. Schematic representation of the pathway of Na⫹-K⫹-ATPase traffic from the plasma membrane to intracellular endosomal and lysosomal compartments and recruitment back of the Na⫹ pumps into the basolateral membranes on cathecholomine stimulation in the alveolar epithelium. dynamic interaction between protein-transporting vesicles, microtubulae, and the actin cytoskeleton as pretreatment with colchicine, brefeldine, or phallacidin prevents this recruitment. Interestingly, the shortterm regulation of Na⫹-K⫹-ATPase in alveolar type 2 epithelial cells by dopamine has been associated with D1a- but not D2-receptor stimulation. These highly regulated processes occur via simultaneous, phosphorylation events regulated by novel protein kinases and dephosphorylation events regulated by protein phosphatase 2A (48, 69). A second, rapid mechanism by which ␤-adrenergic agonists stimulate transepithelial Na⫹ transport and Na⫹-K⫹-ATPase is via cAMP-dependent activation of apical Cl⫺ channels in alveolar epithelial cells (42). Long-term regulatory mechanisms. Long-term regulation of Na⫹-K⫹-ATPase occurs via transcriptional and posttranscriptional mechanisms, including changes in membrane enzyme-specific activity, and increases in plasma membrane Na⫹ pump proteins due to trafficking of heterodimers to the plasma membrane from intracellular pools, translation, protein degradation Fig. 2. Schematic representation of the dopaminergic-receptor (D2R) and ␤2-adrenergic-receptor (␤2-AR) pathways leading to transcriptional and posttranscriptional regulation of the Na⫹ pump protein in alveolar epithelial cells. ERK, extracellular regulated kinase; mTOR, mammalian target of rapamycin; PKA, protein kinase A; PKC, protein Kinase C. J Appl Physiol • VOL 93 • NOVEMBER 2002 • www.jap.org Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022. 1863 INVITED REVIEW rates, mRNA stability, and transcription (reviewed in Refs. 9, 41, 86). Transcriptional regulation of the Na⫹ pump subunit genes is an important component of the multifaceted response to growth hormones, hormonal stimulation, hyperoxia, and cellular stress. The triggers for increased Na⫹-K⫹-ATPase expression in the lung just before birth and the specific transcription factors and signaling pathways that initiate transcription in response to stress or stimulation are being defined. Unequal amounts of ␣ and ␤ mRNA and protein concentrations are present in many tissues, although the final Na⫹ pump ␣- and ␤-subunit stoichiometry is 1:1. Because the subunit genes are on different chromosomes, transcription may be independently regulated. Increased transcription of the Na⫹-K⫹-ATPase subunit genes in the lung may be mediated by hormones such as dexamethasone, insulin, and aldosterone (5, 37, 39, 41, 43, 45, 47, 94, 95). Aldosterone increases both transcription and plasma membrane insertion of preformed pump molecules (25, 64). Both functional enzyme activity and gene transcription are increased by low intracellular K⫹ concentration or high Na⫹ concentration or by various hormones, including thyroid hormone (59), and in the lung by aldosterone (64) and glucocorticoids (41). Corticosteroids, dexamethasone, 3,5,3⬘-triiodothyronine (T3), and aldosterone, as well as keratinocyte growth factor and epidermal growth factor, increase Na⫹ reabsorption in mammalian lungs (11, 18, 27, 28, 31–34, 58, 66, 73, 74, 84, 85). Similar to steroids and growth factors, the commonly used drugs dopamine (via D2 receptors) and ␤-adrenergic agonists can activate Na⫹-K⫹-ATPase gene transcription and translation in alveolar epithelial cells (37) (67). Dopaminergic D2-receptor-mediated stimulation of Na⫹-K⫹ATPase mRNA and protein synthesis occurs via mitogen-activated protein kinases and a Ras-Raf-mitogenactivated protein kinase kinase pathway (37). For example, terbutaline stimulated rat alveolar epithelial cell Na⫹-K⫹-ATPase function after several days (60). A more recent study reported that ␤-adrenergic stimulation of serum-starved alveolar epithelial cells regulated Na⫹-K⫹-ATPase translation via extracellular regulated kinase-rapamycin pathways independent of changes in Na⫹-K⫹-ATPase transcription (67). Translation of Na⫹-K⫹-ATPase mRNA is an important locus of regulation in a variety of settings. For example, similar increases in steady-state levels of mRNA result in different activity levels of the Na⫹ pump, indicating that posttranscriptional steps play a role in the regulation of Na⫹-K⫹-ATPase (36, 67). In vitro studies of translation demonstrated that untranslated mRNA regions can affect subunit translation. The mRNA for ␣1 is translated less efficiently than that for ␤1 because of ␣1 mRNA’s 3⬘ untranslated mRNA region being extremely GC rich and folded in a complex fashion and because translational efficiency may be altered by glucocorticoids (22). J Appl Physiol • VOL OVEREXPRESSION OF Naⴙ-Kⴙ-ATPase IN THE ALVEOLAR EPITHELIUM In several models of lung injury and most ARDS patients, lung edema clearance is impaired (7, 82, 91, 92). Thus methods that improve lung edema clearance might offer a therapeutic option for these patients with acute respiratory failure. For many years, it was believed that the Na⫹ channel was the locus of control for Na⫹ reabsorption, but recent data indicate that upregulation of Na⫹-K⫹-ATPase alone is sufficient to increase alveolar fluid clearance (2, 26, 27). Many of the agents discussed above can stimulate fluid clearance by regulating the alveolar epithelial Na⫹-K⫹ATPase, including dopamine, ␤-adrenergic agonists, glucocorticoids, T3, keratinocyte growth factor, and epidermal growth factor. Because in several models of lung injury models and in many ARDS patients lung edema clearance is impaired, a clinical goal is the augmentation of fluid clearance in patients with decreased or normal levels edema clearance, through increased Na⫹-K⫹-ATPase and/or Na⫹ channel function. The proof-of-concept experiments that augmentation of Na⫹-K⫹-ATPase is a valid approach and can be physiologically beneficial are based on gene transfer experiments. The two gene transfer approaches have been direct transfer of Na⫹-K⫹-ATPase genes and overexpression of the ␤-adrenergic receptor gene to promote the increase of both Na⫹ channels and Na⫹K⫹-ATPase. Adenoviral-mediated gene transfer has been utilized to transduce the alveolar epithelium of rats to study the role of alveolar Na⫹-K⫹-ATPase in lung edema clearance (2, 26, 27). First-generation (E1a⫺/E3⫺), replication-incompetent human type 5 adenoviruses that express rat Na⫹-K⫹-ATPase ␣1- or ␤1-subunit cDNA were used to transduce lung epithelial cells. Overexpression of a ␤1-subunit, but not an ␣1-subunit, increased Na⫹-K⫹-ATPase function in adult rat alveolar epithelial cells and rat fetal distal lung epithelial cells (87). Conversely, Na⫹-K⫹-ATPase function in a human lung cell line (A549) was increased only after overexpression of an ␣1-subunit gene (28). These studies were extended to in vivo models by transducing the alveolar epithelium of normal adult rats using a surfactantbased delivery system that increased alveolar fluid reabsorption by ⬎100% in rat lungs overexpressing a ␤1-subunit gene. As described above, adult rats exposed to 100% O2 develop acute lung injury characterized by increased alveolar permeability, edema accumulation, and impairment of lung liquid clearance (16, 20, 65). A recent study reported the results of adenoviral-mediated overexpression of a Na⫹-K⫹-ATPase ␤1-subunit gene in the alveolar epithelium of adult rats before exposure to hyperoxia (100% O2 for 64 h). Rats overexpressing the Na⫹-K⫹-ATPase ␤1-subunit gene in the alveolar epithelium tolerated hyperoxia better, had no pleural effusions, and had lung liquid clearance rates that were 300% greater than hyperoxic controls or rats infected 93 • NOVEMBER 2002 • www.jap.org Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022. 1864 INVITED REVIEW with an ␣1-subunit-expressing virus. In addition, ␤1subunit overexpression was associated with 100% survival through 14 days of hyperoxia, suggesting that augmentation of lung liquid clearance may confer protection from a severe experimental lung injury. Similarly, Stern et al. (80) reported that mice (C57BL/6) transduced with a chicken ␣3-gene fused to a ␤1 cDNA have increased whole lung Na⫹-K⫹-ATPase activity and less thiourea-induced edema than controls treated with a plasmid vector that encoded an irrelevant cDNA. Recently, in a model of increased left atrial pressures, it was reported that the lung’s ability to clear edema was decreased by 50% as left atrial pressure was increased from 0 to 15 cmH2O in isolated rat lungs (3, 72). Overexpression of Na⫹-K⫹-ATPase ␤1subunit 7 days before measurement of lung liquid clearance improved clearance in this model of increased hydrostatic pulmonary circulation pressures (2). ␤-Adrenergic-receptor overexpression. ␤-Adrenergic agonists increase active Na⫹ transport in alveolar epithelial cells and normal and injured animal lungs by increasing the function of both apical Na⫹ entry pathways via the epithelial Na⫹ channels and Na⫹-K⫹ATPases. These effects result from the stimulation of both ␤1- and ␤2-adrenergic receptors (70, 75, 88), leading to upregulation of Na⫹ channels and Na⫹-K⫹ATPases in the lung epithelium (8, 56, 60, 67). Overexpression of a ␤2-adrenergic receptor in rat alveoli with recombinant adenovirus that expresses a human ␤2-adrenergic-receptor cDNA increased lung liquid clearance by ⬃100% compared with sham-infected rats. The increased lung liquid clearance was associated with increased abundance in peripheral lung of both ␣1-subunit of the epithelial Na⫹ channels in apical membrane fractions and Na⫹-K⫹-ATPase protein abundance in basolateral cell membranes (23). SUMMARY Alveolar epithelial Na⫹-K⫹-ATPases are highly regulated proteins that contribute substantively to the active Na⫹ transport necessary to maintain a dry alveolar air space. A growing body of research indicates that downregulation of alveolar Na⫹-K⫹-ATPases is associated with pulmonary edema in experimental models of lung injury as well as in patients with highand low-pressure pulmonary edema. Thus methods that counterbalance the inhibition of edema clearance during lung injury and improve the lungs ability to clear pulmonary edema are needed. As such, mechanisms that increase Na⫹-K⫹-ATPase function, (i.e., activation of dopaminergic or adrenergic receptors, corticosteroids, gene transfer) represent the rationale for investigation toward the development of therapeutic strategies to regulate the Na⫹-K⫹-ATPase function and increase edema clearance. During these first 20 yr since the demonstration of Matthay et al. (58a) that alveolar edema is cleared by active Na⫹ transport, the importance of alveolar Na⫹-K⫹-ATPases has been clearly established. The mechanisms responsible for J Appl Physiol • VOL regulating the Na⫹ pump are now being actively studied. New experimental data are broadening our understanding of the importance of this crucial protein to lung biology and pathophysiology. This research was supported in part by National Heart, Lung, and Blood Institute Grants HL-48129, HL-50152, HL-65161, and HL66211 and a grant from the Evanston Northwestern Healthcare Research Institute. REFERENCES 1. Artigas A, Bernard GR, Carlet J, Dreyfuss D, Gattinoni L, Hudson L, Lamy M, Marini JJ, Matthay MA, Pinsky MR, Spragg R, and Suter PM. The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling. Intensive Care Med 24: 378–398, 1998. 2. Azzam ZS, Dumasius V, Saldias FJ, Adir Y, Sznajder JI, and Factor P. Na,K-ATPase overexpression improves alveolar fluid clearance in a rat model of elevated left atrial pressure. Circulation 105: 497–501, 2002. 3. Azzam ZS, Saldias F, Comellas A, Ridge K, Rutschman D, and Sznajder J. Catecholamines increase lung edema clearance in rats with increased left atrial pressure. J Appl Physiol 90: 1088–1094, 2001. 4. Barnard ML, Ridge KM, Saldias F, Friedman E, Gare M, Guerrero C, Lecuona E, Bertorello AM, Katz AI, and Sznajder JI. Stimulation of the dopamine 1 receptor increases lung edema clearance. Am J Respir Crit Care Med 160: 982–986, 1999. 5. Barquin N, Ciccolella DE, Ridge KM, and Sznajder JI. Dexamethasone upregulates the Na-K-ATPase in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 273: L825– L830, 1997. 6. Berthiaume Y, Folkesson HG, and Matthay MA. Indomethacin does not influence alveolar liquid clearance in anesthetized sheep or rats. Exp Lung Res 25: 517–530, 1999. 7. Berthiaume Y, Lesur O, and Dagenais A. Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 54: 150–160, 1999. 8. Berthiaume Y, Staub NC, and Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 79: 335–343, 1987. 9. Bertorello AM and Katz A. Regulation of Na:K pump activity: pathways between receptors and effectors. News Physiol Sci 10: 253–259, 1995. 10. Blanco G and Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol Renal Physiol 275: F633–F650, 1998. 11. Borok Z, Hami A, Danto S, Lubman R, Kim K, and Crandall E. Effects of epidermal growth factor on alveolar epithelial junctional permeability and active sodium transport physiology. Am J Physiol Lung Cell Mol Physiol 270: L559–L564, 1996. 12. Borok Z, Liebler JM, Lubman RL, Foster MJ, Zhou B, Li X, Zabski SM, Kim KJ, and Crandall ED. Na transport proteins are expressed by rat alveolar epithelial type I cells. Am J Physiol Lung Cell Mol Physiol 282: L599–L608, 2002. 13. Borok Z, Mihyu S, Fernandes VF, Zhang XL, Kim KJ, and Lubman RL. KGF prevents hyperoxia-induced reduction of active ion transport in alveolar epithelial cells. Am J Physiol Cell Physiol 276: C1352–C1360, 1999. 14. Brower RG, Ware LB, Berthiaume Y, and Matthay MA. Treatment of ARDS. Chest 120: 1347–1367, 2001. 15. Buono R, Ferraro T, Connor M, Sperling M, Abbey M, Finanger E, Lohoff F, Mulholland N, and Berrettini W. Lack of association between temporal lobe epilepsy and novel polymorphism in the alpha 2 subunit gene (ATP1A2) of the sodium potassium transporting ATPase. Am J Med Genet 96: 79–83, 2000. 16. Carter EP, Wangensteen OD, Dunitz J, and Ingbar DH. Hyperoxic effects on alveolar sodium resorption and lung Na-KATPase. Am J Physiol Lung Cell Mol Physiol 273: L1191–L1202, 1997. 93 • NOVEMBER 2002 • www.jap.org Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022. 1865 INVITED REVIEW 17. Clerici C and Matthay MA. Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 88: 1890–1896, 2000. 18. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, and Locksley RM. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183: 109–117, 1996. 19. Crandall ED and Matthay MA. Alveolar epithelial transport. Basic science to clinical medicine. Am J Respir Crit Care Med 163: 1021–1029, 2001. 20. Crapo J, Barry B, Foscue H, and Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 122: 123–143, 1980. 21. Derfoul A, Robertson NM, Lingrel JB, Hall DJ, and Litwack G. Regulation of the human Na/K-ATPase ␤1 gene promoter by mineralocorticoid and glucocorticoid receptors. J Biol Chem 273: 20702–20711, 1998. 22. Devarajan P, Gilmore-Hebert M, and Benz EJ Jr. Differential translation of the Na,K-ATPase subunit mRNAs. J Biol Chem 267: 22435–22439, 1992. 23. Dumasius V, Sznajder JI, Azzam ZS, Boja J, Mutlu GM, Maron MB, and Factor P. ␤(2)-Adrenergic receptor overexpression increases alveolar fluid clearance and responsiveness to endogenous catecholamines in rats. Circ Res 89: 907–914, 2001. 24. Effros RM, Mason GR, Hukkanen J, and Silverman P. New evidence for active sodium transport from fluid-filled rat lungs. J Appl Physiol 66: 906–919, 1989. 25. Ewart H and Klip A. Hormonal regulation of the Na-KATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol Cell Physiol 269: C295–C311, 1995. 26. Factor P, Dumasius V, Brown LA, and Sznajder JI. Adenovirus-mediated transfer of an Na⫹/K⫹-ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats. Hum Gene Ther 11: 2231–2242, 2000. 27. Factor P, Saldias F, Ridge K, Dumasius V, Zabner J, Jaffe HA, Blanco G, Barnard M, Mercer R, Perrin R and Sznajder JI. Augmentation of lung liquid clearance via adenovirusmediated transfer of a Na,K-ATPase ␤1 subunit gene. J Clin Invest 102: 1421–1430, 1998. 28. Factor P, Senne C, Dumasius V, Ridge K, Jaffe HA, Uhal B, Gao Z, and Sznajder JI. Overexpression of the Na⫹,K⫹ATPase ␣1 subunit increases Na⫹,K⫹-ATPase function in A549 cells. Am J Respir Cell Mol Biol 18: 741–749, 1998. 29. Feng ZP, Clark RB, and Berthiaume Y. Identification of nonselective cation channels in cultured adult rat alveolar type II cells. Am J Respir Cell Mol Biol 9: 248–254, 1993. 30. Feraille E, Beguin P, Carranza M, Gonin S, Rousselot M, Martin P, Favre H, and Geering K. Is phosphorylation of the ␣1 subunit at Ser-16 involved in the control of Na,K-ATPase activity by phorbol ester-activated protein kinase C? Mol Biol Cell 11: 39–50, 2000. 31. Folkesson HG, Matthay MA, Frigeri A, and Verkman AS. Transepithelial water permeability in microperfused distal airways. Evidence for channel-mediated water transport. J Clin Invest 97: 664–671, 1996. 32. Folkesson HG, Matthay MA, Westrom BR, Kim KJ, Karlsson BW, and Hastings RH. Alveolar epithelial clearance of protein. J Appl Physiol 80: 1431–1445, 1996. 33. Folkesson HG, Pittet JF, Nitenberg G, and Matthay MA. Transforming growth factor-␣ increases alveolar liquid clearance in anesthetized ventilated rats. Am J Physiol Lung Cell Mol Physiol 271: L236–L244, 1996. 34. Garat C, Kheradmand F, Albertine KH, Folkesson HG, and Matthay MA. Soluble and insoluble fibronectin increases alveolar epithelial wound healing in vitro. Am J Physiol Lung Cell Mol Physiol 271: L844–L853, 1996. 35. Garat C, Meignan M, Matthay MA, Luo DF, and Jayr C. Alveolar epithelial fluid clearance mechanisms are intact after moderate hyperoxic lung injury in rats. Chest 111: 1381–1388, 1997. 36. Gick G, Hatala M, Chon D, and Ismail-Beigi F. Na,K-ATPase in several tissues of the rat: tissue specific expression of subunit mRNAs and enzyme activity. Membr Biol 131: 229–236, 1993. J Appl Physiol • VOL 37. Guerrero C, Lecuona E, Pesce L, Ridge K, and Sznajder J. Dopamine regulates Na-K-ATPase in alveolar epithelial cells via MAPK-ERK-dependent mechanisms. Am J Physiol Lung Cell Mol Physiol 281: L79–L85, 2001. 38. Heffner JE and Matthay MA. The case for oxidants in the adult respiratory distress syndrome—“elementary, Dr. Watson.” J Lab Clin Med 115: 394–395, 1990. 39. Horisberger J, Lemas V, Kraehenbuhl J, and Rossier B. Structure function relationship of Na,K-ATPase. Annu Rev Physiol 53: 565–584, 1991. 40. Hu P, Ischiropoulos H, Beckman JS, and Matalon S. Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 266: L628–L634, 1994. 41. Ingbar DH. Lung Na,K-ATPase in pulmonary edema. In: Pulmonary Edema, edited by Matthay MA and Ingbar DH. New York: Dekker, 1998. 42. Jiang X, Ingbar D, and O’Grady S. Adrenergic regulation of ion transport across adult alveolar epithelial cells: effects on C1-channel activation and transport function in cultures with an apical air interface. J Membr Biol 181: 195–204, 2001. 43. Jiang X, Ingbar DH, and O’Grady SM. Adrenergic stimulation of Na⫹ transport across alveolar epithelial cells involves activation of apical Cl⫺ channels. Am J Physiol Cell Physiol 275: C1610–C1620, 1998. 44. Johnson M, Widdicombe J, Allen L, Barbry P, and Dobbs L. Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci USA 99: 1966–1971, 2002. 45. Jyonouchi H, Sun S, Abiru T, Chareancholvanich S, and Ingbar DH. The effects of hyperoxic injury and antioxidant vitamins on death and proliferation of human small airway epithelial cells. Am J Respir Cell Mol Biol 19: 426–436, 1998. 46. Kolla V, Robertson N, and Litwack G. Identification of mineralocorticoid/glucocorticoid response element in the human Na,K-ATPase ␣1 gene promoter. Biochem Biophys Res Commun 266: 5–14, 1999. 47. Lasnier JM, Ingbar DH, Carter EP, Wilson K, McKnite S, Lurie KG, and Wangensteen OD. Perfusion technique determines alveolar fluid resorption rate in the isolated perfused rat lung. J Appl Physiol 84: 740–745, 1998. 48. Lecuona E, Garcia A, and Sznajder JI. A novel role for protein phosphatase 2A in the dopaminergic regulation of Na,KATPase. FEBS Lett 481: 217–220, 2000. 49. Lecuona E, Saldias F, Comellas A, Ridge K, Guerrero C, and Sznajder JI. Ventilator-associated lung injury decreases lung ability to clear edema in rats. Am J Respir Crit Care Med 159: 603–609, 1999. 50. Lingrel J, Young R, and Shull M. Multiple forms of the Na,K-ATPase: their gene and tissue specific expression. Prog Clin Biol Res 268B: 105–112, 1988. 51. Lingrel JB, Orlowski J, Price EM, and Pathak BG. Regulation of the alpha-subunit genes of the Na,K-ATPase and determinants of cardiac glycoside sensitivity. Soc Gen Physiol Ser 46: 1–16, 1991. 52. Lingrel JB, Van Huysse J, O’Brien W, Jewell-Motz E, Askew R, and Schultheis P. Structure-function studies of the Na,K-ATPase. Kidney Int Suppl 44: S32–S39, 1994. 53. Liu B and Gick G. Characterization of the 5⬘ flanking region of the rat Na,K-ATPase ␤1 subunit gene. Biochim Biophys Acta 1130: 336–338, 1992. 54. Mairbaurl H, Mayer K, Kim KJ, Borok Z, Bartsch P, and Crandall ED. Hypoxia decreases active Na transport across primary rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 282: L659–L665, 2002. 55. Mairbaurl H, Wodopia R, Eckes S, Schulz S, and Bartsch P. Impairment of cation transport in A549 cells and rat alveolar epithelial cells by hyperoxia. Am J Physiol Lung Cell Mol Physiol 273: L797–L806, 1997. 56. Matalon S, Benos DJ, and Jackson RM. Biophysical and molecular properties of amiloride-inhibitable Na⫹ channels in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 271: L1–L22, 1996. 93 • NOVEMBER 2002 • www.jap.org Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022. 1866 INVITED REVIEW 57. Matalon S and O’Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 61: 627– 661, 1999. 58. Matthay MA, Folkesson HG, and Verkman AS. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol Lung Cell Mol Physiol 270: L487– L503, 1996. 58a.Matthay MA, Landolt CC, and Staub NC. Differential liquid and protein clearance from the alveoli of anesthetized sheep. J Appl Physiol 53: 96 – 104, 1982. 59. McDonough A, Geering K, and Farley R. The sodium pump needs its ␤ subunit. FASEB J 4: 1598–1605, 1990. 60. Minakata Y, Suzuki S, Grygorczyk C, Dagenais A, and Berthiaume Y. Impact of ␤-adrenergic agonist on Na⫹ channel and Na⫹-K⫹-ATPase expression in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 275: L414–L422, 1998. 61. Mobasheri A, Avila A, Cozar I, Brownleader M, Trevan M, Francis M, Lamb J, and Martin-Vasallo P. Na,K ATPase isozyme diversity: comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 20: 51– 91, 2000. 62. Nici L, Dowin R, Gilmore-Hebert M, Jamieson JD, and Ingbar DH. Upregulation of rat lung Na-K-ATPase during hyperoxic injury. Am J Physiol Lung Cell Mol Physiol 261: L307–L314, 1991. 63. Olivera W, Ridge K, Wood LD, and Sznajder JI. Active sodium transport and alveolar epithelial Na-K-ATPase increase during subacute hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 266: L577–L584, 1994. 64. Olivera WG, Ciccolella DE, Barquin N, Ridge KM, Rutschman DH, Yeates DB, and Sznajder JI. Aldosterone regulates Na,K-ATPase and increases lung edema clearance in rats. Am J Respir Crit Care Med 161: 567–573, 2000. 65. Olivera WG, Ridge KM, and Sznajder JI. Lung liquid clearance and Na,K-ATPase during acute hyperoxia and recovery in rats. Am J Respir Crit Care Med 152: 1229–1234, 1995. 66. Pardo A, Barrios R, Maldonado V, Melendez J, Perez J, Ruiz V, Segura-Valdez L, Sznajder JI, and Selman M. Gelatinases A and B are upregulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 153: 833– 844, 1998. 67. Pesce L, Guerrero C, Comellas A, Ridge K, and Sznajder J. Beta agonists regulate Na,K-ATPase via novel MAPK/ERK and rapamycin-sensitive pathways. FEBS Lett 486: 310–314, 2000. 68. Rankinen T, Perusse L, Borecki I, Chagnon Y, Gagnon J, Leon A, Skinner J, Wilmore J, Rao D, and Bouchard C. The Na⫹-K⫹-ATPase ␣2 gene and trainability of cardiorespiratory endurance: the HERITAGE Family study. J Appl Physiol 88: 346–351, 2000. 69. Ridge K, Dada L, Lecuona E, Bertorello A, Katz A, MochlyRosen D, and Sznajder J. Dopamine-induced exocytosis of the Na,K-ATPase is dependent on the activation of protein kinase C delta and epsilon. Mol Biol Cell 13: 1381–1389, 2002. 70. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, and Matthay MA. ␤-Adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 155: 506–512, 1997. 71. Sakuma T, Okaniwa G, Nakada T, Nishimura T, Fujimura S, and Matthay MA. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med 150: 305–310, 1994. 72. Saldias F, Azzam Z, Ridge K, Yeldandi A, Rutschman D, Schraufnagel D, and Sznajder J. Alveolar fluid reabsorption is impaired by increased left atrial pressure in rats. Am J Physiol Lung Cell Mol Physiol 281: L591–L597, 2001. 73. Saldias F, Lecuona E, Friedman E, Barnard ML, Ridge KM, and Sznajder JI. Modulation of lung liquid clearance by isoproterenol in rat lungs. Am J Physiol Lung Cell Mol Physiol 274: L694–L701, 1998. 74. Saldias FJ, Comellas A, Guerrero C, Ridge KM, Rutschman DH, and Sznajder JI. Time course of active and passive liquid and solute movement in the isolated perfused rat lung model. J Appl Physiol 85: 1572–1577, 1998. J Appl Physiol • VOL 75. Saldias FJ, Lecuona E, Comellas AP, Ridge KM, Rutschman DH, and Sznajder JI. ␤-Adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. Am J Respir Crit Care Med 162: 282–287, 2000. 76. Saumon G and Basset G. Electrolyte and fluid transport across the mature alveolar epithelium. J Appl Physiol 74: 1–15, 1993. 77. Shull MM, Pugh DG, and Lingrel JB. The human Na,KATPase ␣1 gene: characterization of the 5⬘-flanking region and identification of a restriction fragment length polymorphism. Genomics 6: 451–460, 1990. 78. Skou JC. The Na-K pump. News Physiol Sci 7: 95–100, 1992. 79. Skou JC. Nobel Lecture: the identification of the sodium pump. Biosci Rep 18: 155–169, 1998. 80. Stern M, Ulrich K, Robinson C, Copeland J, Griesenbach U, Masse C, Cheng S, Munkonge F, Geddes D, Berthiaume Y, and Alton E. Pretreatment with cationic lipid-mediated transfer of the Na⫹-K⫹-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema. Gene Ther 7: 960–966, 2000. 81. Suzuki-Yagawa Y, Kawakami K, and Nagano K. Housekeeping Na,K-ATPase ␣1 subunit gene promoter is composed of multiple cis elements to which common and cell type-specific factors bind. Mol Cell Biol 12: 4046–4055, 1992. 82. Sznajder J. Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am J Respir Cell Mol Biol 163: 1293–1294, 2001. 83. Sznajder JI. Strategies to increase alveolar epithelial fluid removal in the injured lung. Am J Respir Crit Care Med 160: 1441–1442, 1999. 84. Sznajder JI, Nahum A, Hansen DE, Long GR, and Wood LD. Volume recruitment and oxygenation in pulmonary edema: a comparison between HFOV and CMV. J Crit Care 13: 126–135, 1998. 85. Sznajder JI, Ridge KM, Yeates DB, Ilekis J, and Olivera W. Epidermal growth factor increases lung liquid clearance in rat lungs. J Appl Physiol 85: 1004–1010, 1998. 86. Therien AG and Blostein R. Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol 279: C541–C566, 2000. 87. Thome U, Chen L, Fayemi O, Dumasius V, Freeman BA, Sznajder JI, and Matalon S. Na,K-ATPase gene transfer mitigates an oxidant-induced decrease of active sodium transport in rat fetal ATII cells. Am J Respir Cell Mol Biol 24: 245–252, 2001. 88. Tibayan FA, Chesnutt AN, Folkesson HG, Eandi J, and Matthay MA. Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation. Am J Respir Crit Care Med 156: 438–444, 1997. 89. Verghese GM, Ware LB, Matthay BA, and Matthay MA. Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol 87: 1301– 1312, 1999. 90. Vivona ML, Matthay M, Chabaud MB, Friedlander G, and Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by ␤-adrenergic agonist treatment. Am J Respir Cell Mol Biol 25: 554–561, 2001. 91. Ware LB and Matthay M. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 163: 1376–1383, 2001. 92. Ware LB and Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334–1349, 2000. 93. Wendt C, Gick G, Sharma R, Zhuang Y, Deng W, and Ingbar D. Upregulation of Na,K-ATPase ␤1 transcription is mediated by SP1/SP3. J Biol Chem 275: 41396–41404, 2000. 94. Wendt CH, Sharma R, Bair R, Towle H, and Ingbar DH. Oxidant effects on epithelial Na,K-ATPase gene expression and promoter function. Environ Health Perspect 106, Suppl 5: 1213– 1217, 1998. 95. Wendt CH, Towle H, Sharma R, Duvick S, Kawakami K, Gick G, and Ingbar DH. Regulation of Na-K-ATPase gene expression by hyperoxia in MDCK cells. Am J Physiol Cell Physiol 274: C356–C364, 1998. 96. Yagawa Y, Kawakami K, and Nagano K. Cloning and analysis of the 5⬘-flanking region of rat Na,K-ATPase alpha subunit gene. Biochim Biophys Acta 1049: 286–292, 1990. 93 • NOVEMBER 2002 • www.jap.org Downloaded from journals.physiology.org/journal/jappl (003.090.248.229) on January 17, 2022.